SP
SUPERNUS PHARMACEUTICALS INC
SUPN· Health Care· PharmaceuticalsS&P 600
Close · 15/09/2026
41.28
1D
-0.51%52-week range
40.51 – 59.68
Volume
6,69,200.00
Price history
SUPN
14/08/2026 to 15/09/2026
O 41.49 H 41.75 L 40.51
1W-2.71%
1M-14.48%
3M-5.88%
6M-17.79%
1Y-9.19%
3Y+34.95%
5Y+51.26%
MAX+48.28%
Fundamentals
as of 15/09/2026- Market cap
- $2.40B
- Shares out
- 58.13M
- P/E (forward)
- 9.34
- EPS (trailing)
- -1.89
- Beta
- 0.56
- Profit margin
- -13.23%
- P/B
- 2.33
- Return on equity
- -10.66%
SEC financial statements
56 quarterly and 16 annual periods through 30/06/2026.
Details
- Ticker
- SUPN
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 15/09/2026.
Tracked by Congress
2 filers · 1 on watchlist · 3 buys · 2 sells · D: 5
- 03/03/2026Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/12/2025Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 09/10/2025Gilbert CisnerosSell+Supernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 24/03/2025Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 23/12/2022Josh GottheimerWSell+Supernus Pharmaceuticals, Inc.$1,001–$15,000